Significance of new lung infiltrates in outpatients after lung and heart–lung transplantation. Issue 3 (12th April 2014)

• Record Type: Journal Article
• Authors: Díaz‐Ravetllat, V.; Greer, M.; Haverich, A.; Warnecke, G.; Dierich, M.; Welte, T.; Gottlieb, J.
• Is Part Of: Transplant infectious disease. Volume 16:Issue 3(2014)
• Page Start: 359
• Page End: 368
• Publication Date: 2014-04-12
• Subjects: Transplantation of organs, tissues, etc -- Complications -- Periodicals; Communicable diseases -- Periodicals; Infection -- Periodicals; 617.01
• DOI: 10.1111/tid.12209
• Languages: English
• ISSNs: 1398-2273

Abstract

<abstract abstract-type="main" id="tid12209-abs-0001"> <title>Abstract</title> <sec id="tid12209-sec-0001" sec-type="section"> <title>Background</title> <p>Infection and rejection represent major complications following lung transplantation and are often associated with pulmonary infiltrates. The differential diagnosis of these infiltrates depends on their timing after transplantation. The aim of this study was to characterize lung transplant recipients (LTR) presenting with new pulmonary infiltrates.</p> </sec> <sec id="tid12209-sec-0002" sec-type="section"> <title>Methods</title> <p>A retrospective analysis of all LTR and heart–lung transplant recipients attending outpatient follow‐up at our institution between September 1, 2006 and October 14, 2011 was performed. All patients presenting with new pulmonary infiltrates on chest x‐ray who underwent bronchoscopy were included.</p> </sec> <sec id="tid12209-sec-0003" sec-type="section"> <title>Results</title> <p>A total of 913 patients accounted for 13, 156 attendances, with 3, 912 bronchoscopies being performed. Seventy‐eight patients (9%) exhibited new pulmonary infiltrates and proceeded to bronchoscopy. Infiltrates occurred at a median 15 (interquartile range [IQR] 5–39) months after transplantation. Forty‐eight patients (62%) were male, and median patient age was 47 (IQR 29–57) years. Subsequent investigation revealed pneumonia to be the underlying cause in 63 patients (81%). In the remaining patients, chronic lung allograft dysfunction (CLAD) was responsible in 6 (8%), acute rejection in 5 (6%), and toxic pneumonitis in 4 (5%) patients. Overall 1‐year survival in LTR presenting with new infiltrates was 97%, compared with 96% for all LTR attending our Outpatient Department.</p> </sec> <sec id="tid12209-sec-0004" sec-type="section"> <title>Conclusions</title> <p>New pulmonary infiltrates occurring after the first month in LTR are most likely due to infection. Through prompt diagnosis and treatment, early mortality appears unaffected. Late mortality remains attributable to CLAD.</p> </sec> </abstract>